RPL13 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.753400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.285600E-01
Normal-vs-Stage2
6.830600E-01
Normal-vs-Stage3
7.849200E-01
Normal-vs-Stage4
4.178200E-01
Stage1-vs-Stage2
9.145400E-01
Stage1-vs-Stage3
6.160400E-01
Stage1-vs-Stage4
6.552800E-01
Stage2-vs-Stage3
3.986000E-01
Stage2-vs-Stage4
5.756600E-01
Stage3-vs-Stage4
2.017000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.255800E-01
Normal-vs-AfricanAmerican
8.273000E-01
Normal-vs-Asian
7.213000E-01
Caucasian-vs-AfricanAmerican
7.284000E-01
Caucasian-vs-Asian
6.855800E-01
AfricanAmerican-vs-Asian
5.951800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.888200E-01
Normal-vs-Female
8.276200E-01
Male-vs-Female
1.000240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.894200E-01
Normal-vs-Age(41-60Yrs)
8.209600E-01
Normal-vs-Age(61-80Yrs)
6.912400E-01
Normal-vs-Age(81-100Yrs)
2.362200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.054600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.786600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.037400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.791200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.558500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.713900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.007800E-01
Normal-vs-Daily Drinker
4.338400E-01
Normal-vs-Weekly Drinker
6.621000E-01
Normal-vs-Occasional Drinker
4.682600E-01
Normal-vs-Social Drinker
8.193400E-01
Non Drinker-vs-Daily Drinker
5.190600E-01
Non Drinker-vs-Weekly Drinker
6.214800E-01
Non Drinker-vs-Occasional Drinker
8.734200E-01
Non Drinker-vs-Social Drinker
8.418600E-01
Daily Drinker-vs-Weekly Drinker
8.173200E-01
Daily Drinker-vs-Occasional Drinker
6.270400E-01
Daily Drinker-vs-Social Drinker
5.265200E-01
Weekly Drinker-vs-Occasional Drinker
6.644200E-01
Weekly Drinker-vs-Social Drinker
5.740000E-01
Occasional Drinker-vs-Social Drinker
7.673400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.707000E-01
Normal-vs-Grade 2
8.874200E-01
Normal-vs-Grade 3
9.512400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.139600E-01
Grade 1-vs-Grade 3
4.921200E-01
Grade 1-vs-Grade 4
8.707000E-01
Grade 2-vs-Grade 3
4.855200E-01
Grade 2-vs-Grade 4
8.874200E-01
Grade 3-vs-Grade 4
9.512400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.498400E-01
Normal-vs-NonDiabetic
6.335200E-01
Diabetic-vs-NonDiabetic
6.641000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.920400E-01
Normal-vs-NoPancreatitis
6.190400E-01
Pancreatitis-vs-NoPancreatitis
4.173600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.026000E-01
Normal-vs-N1
7.416200E-01
N0-vs-N1
1.516190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.311800E-01
Normal-vs-TP53-NonMutant
7.801000E-01
TP53-Mutant-vs-TP53-NonMutant
3.391200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
